 
 
GtoPdb is requesting financial support from commercial users. Please see our sustainability page for more information.
| 
                                                                Synonyms: MOXR 0916 | MOXR0916 | pogalizumab (deleted INN) | RG7888 | RO7021608
                                 Compound class: 
                                                            Antibody
                                 
                                    
                                        Comment: Vonlerolizumab (MOXR0916) was an investigational humanized anti-human OX40 monoclonal, with reported preclinical efficacy [1]. Genentech terminated their Phase 2 trial NCT03029832 and have discontinued further development.
                                    
                                 | 
| Classification  | |
| Compound class | Antibody | 
| International Nonproprietary Names  | |
| INN number | INN | 
| 10272 | vonlerolizumab | 
| Synonyms  | 
| MOXR 0916 | MOXR0916 | pogalizumab (deleted INN) | RG7888 | RO7021608 | 
| Database Links  | |
| Specialist databases | |
| IMGT/mAb-DB | 608 | 
| Other databases | |
| GtoPdb PubChem SID | 315661320 | 
| Search PubMed clinical trials | vonlerolizumab | 
| Search PubMed titles | vonlerolizumab | 
| Search PubMed titles/abstracts | vonlerolizumab |